Urolastic—A New Bulking Agent for the Treatment of Women with Stress Urinary Incontinence: Outcome of 12 Months Follow Up

Objective. To evaluate the efficacy and safety of the new injectable implant, Urolastic, in women with stress urinary incontinence (SUI) after 12-month followup. Materials and Methods. A prospective, cohort study included adult women with SUI. Patients were treated with Urolastic periurethral inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Zajda, Janusz, Farag, Fawzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881341/
https://www.ncbi.nlm.nih.gov/pubmed/24454351
http://dx.doi.org/10.1155/2013/724082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881341/
https://www.ncbi.nlm.nih.gov/pubmed/24454351
http://dx.doi.org/10.1155/2013/724082

Ejemplares similares